Product Overview
SLU-PP-332 is a synthetic small-molecule compound developed at Saint Louis University. It is not a peptide, but it is supplied and studied alongside research peptides.
The compound acts as a pan-agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ, with its strongest activity at ERRα. These orphan nuclear receptors sit upstream of mitochondrial biogenesis, fatty-acid oxidation, and related aerobic gene programs. SLU-PP-332 was first characterized in peer-reviewed literature by the Burris laboratory (ACS Chemical Biology, 2023). It is now studied mainly in preclinical metabolic and mitochondrial research.
Important Note
This product is not approved for human consumption, medical or veterinary use, or diagnostic purposes. It is supplied for laboratory research only and should be handled by qualified professionals in a controlled research setting.
Specifications
| Specification | Detail |
|---|---|
| Compound Type | Synthetic small molecule (not a peptide) |
| Target | Pan-agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ) |
| Vial Content | 10mg |
| Form | Lyophilized powder |
| Storage | Store below –20°C. Keep away from light. |
| Vial | Clear borosilicate glass, butyl rubber stopper, aluminum crimp closure |
| Purity | 99%+ (HPLC-UV) |
| Testing Lab | Janoshik |
| Lab Report | Janoshik #211927 (Verification Key: 3ECHA3RAWPDN) |
Features & Properties
- Synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ), most active at ERRα
- Studied for mitochondrial biogenesis through the ERR–PGC-1α transcriptional network
- Examined in fatty-acid oxidation and oxidative muscle-fiber research
- Used in preclinical metabolic and mitochondrial research models
- Supplied as a lyophilized powder for stability during storage and transport
Storage & Stability
- Store the lyophilized powder at –20°C, where it remains stable for up to 24 months
- Avoid repeated freeze–thaw cycles
- Protect from light and moisture at all times
Usage Restrictions
- For laboratory research use only
- Not approved for human consumption, medical or veterinary use, or diagnostic purposes
- Handling should be carried out by qualified professionals in controlled research settings
- Store securely and keep out of reach of children
- Do not handle during pregnancy or breastfeeding
Frequently Asked Questions
Q1. What does each vial contain?
Each vial contains 10mg of SLU-PP-332 as a sterile lyophilized powder.
Q2. Is SLU-PP-332 a peptide?
No. It is a synthetic small-molecule compound, but it is supplied and studied alongside research peptides.
Q3. What does the product look like?
A fine white to off-white powder that sits at the base of the vial.
Q4. How should it be stored?
Keep it at –20°C, away from light and moisture. Stored this way, it remains stable for up to 24 months.
Q5. Is it sterile?
It is manufactured and sealed under sterile laboratory conditions. Standard sterile handling still applies in the lab.
Q6. Is this product for human use?
No. It is intended for laboratory research only and is not approved for medical or veterinary use.
Q7. Has this product been third-party tested?
Yes. It has been tested by Janoshik, with purity listed at 99%+ (HPLC-UV) (Report #211927). The report can be viewed through the COA / Testing link on this page.
Q8. What is the vial packaging?
A clear borosilicate glass vial sealed with a butyl rubber stopper and an aluminum crimp closure.
Q9. Is the product stable during shipping?
The lyophilized form holds up under standard shipping conditions. Move it to –20°C storage as soon as it arrives.
Q10. Who can handle this product?
Only qualified laboratory researchers trained in compound handling and using proper protective equipment.





